This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Alemtuzumab News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Alemtuzumab News

Sort by: relevance (24 hours) relevance date
  • Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, M.D., FACP, to Chief Medical Officer 3 Nov 2009 13:50 GMT
    ... non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced the appointment ... the company prepares to submit a new drug application (NDA) and bring to market liprotamase, ... including oncology therapies Velcade(R) (bortezomib) and Campath(R) (alemtuzumab). Dr. Brettman received his M.D. from Baylor ...

  • Genmab to Sell Manufacturing Facility and Cut 300 Jobs 5 Nov 2009 18:52 GMT
    ... Genmab is best at and what the pharmaceutical industry needs most—innovation,” notes Lisa N. Drakeman, ... fully human CD20 antibody, Arzerra™, as a treatment for patients with chronic lymphocytic leukemia (CLL) ... (CLL) that is refractory to fludarabine and alemtuzumab. During August Genmab announced positive Phase II ...

  • Genmab shares slide as US facility goes up for sale 6 Nov 2009 12:57 GMT
    ... a month after the US Food and Drug Administration approved Arzerra (ofatumumab) for chronic lymphocytic ... (ofatumumab) for chronic lymphocytic leukaemia as a treatment for patients who have not responded to ... have not responded to Genzyme Corp’s Campath (alemtuzumab) or the chemotherapy fludarabine. The drug was ...

  • FDA Approves New Leukemia Drug 31 Oct 2009 08:57 GMT
    ... This week the US Food and Drug Administration (FDA) approved ofatumumab (Arzerra) for the ... Administration (FDA) approved ofatumumab (Arzerra) for the treatment of that is not responding to fludarabine (Fludara) or alemtuzumab (Campath). The drug, made by GlaxoSmithKline and ...


1 - 4 / 4

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS ALEMTUZUMAB NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.